{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:22:56Z","timestamp":1761823376475},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00347-010-2186-8","type":"journal-article","created":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T12:17:17Z","timestamp":1304338637000},"page":"417-424","source":"Crossref","is-referenced-by-count":3,"title":["Klinische und neuroradiologische Diagnostik bei endokriner Orbitopathie"],"prefix":"10.1007","volume":"108","author":[{"given":"F.","family":"Beisse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pieh-Beisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.","family":"Lagr\u00e8ze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,4]]},"reference":[{"key":"2186_CR1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9394(14)72666-2","volume":"120","author":"Bartley","year":"1995","unstructured":"Bartley GB, Fatourechi V, Kadrmas EF et al (1995) The incidence of Graves\u2018 ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmol 120(4):511\u2013517","journal-title":"Am J Ophthalmol"},{"key":"2186_CR2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/thy.1997.7.885","volume":"7","author":"Gerding","year":"1997","unstructured":"Gerding MN, Terwee CB, Dekker FW et al (1997) Quality of life in patients with Graves\u2018 ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 7(6):885\u2013889","journal-title":"Thyroid"},{"key":"2186_CR3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson A et al (2008) Consensus statement of the European Group on Graves\u2018 Orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158(3):273\u2013285","journal-title":"Eur J Endocrinol"},{"key":"2186_CR4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/105072502761016476","volume":"12","author":"Wiersinga","year":"2002","unstructured":"Wiersinga WM, Bartalena L (2002) Epidemiology and prevention of Graves\u2018 ophthalmopathy. Thyroid 12(10):855\u2013860","journal-title":"Thyroid"},{"key":"2186_CR5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","volume":"121","author":"Bartley","year":"1996","unstructured":"Bartley GB, Fatourechi V, Kadrmas EF et al (1996) Clinical features of Graves\u2018 ophthalmopathy in an incidence cohort. Am J Ophthalmol 121(3):284\u2013290","journal-title":"Am J Ophthalmol"},{"key":"2186_CR6","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","volume":"91","author":"Eckstein","year":"2006","unstructured":"Eckstein AK, Plicht M, Lax H et al (2006) Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2018 ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 91(9):3464\u20133470","journal-title":"J Clin Endocrinol Metab"},{"key":"2186_CR7","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2002-030010","volume":"88","author":"Bahn","year":"2003","unstructured":"Bahn RS (2003) Clinical review 157: Pathophysiology of Graves\u2018 ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab 88(5):1939\u20131946","journal-title":"J Clin Endocrinol Metab"},{"key":"2186_CR8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.329.7462.385","volume":"329","author":"Cawood","year":"2004","unstructured":"Cawood T, Moriarty P, O\u2019Shea D (2004) Recent developments in thyroid eye disease. BMJ 329(7462):385\u2013390","journal-title":"BMJ"},{"key":"2186_CR9","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo.82.7.773","volume":"82","author":"Terwee","year":"1998","unstructured":"Terwee CB, Gerding MN, Dekker FW et al (1998) Development of a disease specific quality of life questionnaire for patients with Graves\u2018 ophthalmopathy: the GO-QOL. Br J Ophthalmol 82(7):773\u2013779","journal-title":"Br J Ophthalmol"},{"key":"2186_CR10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/eje.1.02230","volume":"155","author":"Wiersinga","year":"2006","unstructured":"Wiersinga WM, Perros P, Kahaly GJ et al (2006) Clinical assessment of patients with Graves\u2018 orbitopathy: the European Group on Graves\u2018 Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 155(3):387\u2013389","journal-title":"Eur J Endocrinol"},{"key":"2186_CR11","first-page":"283","volume":"Endocrinol","author":"Dickinson","year":"2001","unstructured":"Dickinson AJ, Perros P (2001) Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol (Oxf) 55(3):283\u2013303","journal-title":"Clin"},{"key":"2186_CR12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-9394(77)90140-4","volume":"83","author":"Werner","year":"1977","unstructured":"Werner SC (1977) Modification of the classification of the eye changes of Graves\u2018 disease. Am J Ophthalmol 83(5):725\u2013727","journal-title":"Am J Ophthalmol"},{"key":"2186_CR13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bjo.2006.094607","volume":"91","author":"McKeag","year":"2007","unstructured":"McKeag D, Lane C, Lazarus JH et al (2007) Clinical features of dysthyroid optic neuropathy: a European Group on Graves\u2018 Orbitopathy (EUGOGO) survey. Br J Ophthalmol 91(4):455\u2013458","journal-title":"Br J Ophthalmol"},{"key":"2186_CR14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0161-6420(81)34997-5","volume":"88","author":"Trobe","year":"1981","unstructured":"Trobe JD (1981) Optic nerve involvement in dysthyroidism. Ophthalmology 88(6):488\u2013492","journal-title":"Ophthalmology"},{"key":"2186_CR15","first-page":"145","volume":"Endocrinol","author":"Terwee","year":"2005","unstructured":"Terwee CB, Prummel MF, Gerding MN et al (2005) Measuring disease activity to predict therapeutic outcome in Graves\u2018 ophthalmopathy. Clin Endocrinol (Oxf) 62(2):145\u2013155","journal-title":"Clin"},{"key":"2186_CR16","unstructured":"M\u00fcller-Forell W, Pitz S (2006) Endocrine orbitopathy. In: M\u00fcller-Forell W (Hrsg) Imaging of orbital and visual pathway pathology. Springer, Berlin, S 213\u2013220"},{"key":"2186_CR17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1259\/bjr\/56958444","volume":"82","author":"Dodds","year":"2009","unstructured":"Dodds NI, Atcha AW, Birchall D, Jackson A (2009) Use of high-resolution MRI of the optic nerve in Graves\u2018 ophthalmopathy. Br J Radiol 82(979):541\u2013544","journal-title":"Br J Radiol"},{"key":"2186_CR18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/eje.0.1450107","volume":"145","author":"Kahaly","year":"2001","unstructured":"Kahaly GJ (2001) Imaging in thyroid-associated orbitopathy. Eur J Endocrinol 145(2):107\u2013118","journal-title":"Eur J Endocrinol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-010-2186-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-010-2186-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-010-2186-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:51:01Z","timestamp":1559051461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-010-2186-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["2186"],"URL":"https:\/\/doi.org\/10.1007\/s00347-010-2186-8","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}